Raftopoulos, Harry

Universidad de Las Palmas de Gran Canaria · Merck & Co., Inc., Rahway, NJ, USA (United States) · Hospital Universitario Fundación Jiménez Díaz · Hospital Universitario Central de Asturias · Vall d'Hebron Institute of Oncology · NYU Langone’s Laura and Isaac Perlmutter Cancer Center · New York University

2 papers on CoChat

Most cited papers

Verified
Pembrolizumab plus chemotherapy in metastatic non–small-cell lung cancer
Gandhi, L., Rodríguez-Abreu, D., Gadgeel, S., Esteban, E., Felip, E., De Angelis, F., Domine, M., Clingan, P., Hochmair, M. J., Powell, S. F., et al. (2018) · New England Journal of Medicine
Lung Cancer Treatments and MutationsCancer Immunotherapy and Biomarkers
Cited by 6,607
Verified
Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study
Langer, C. J., Gadgeel, S. M., Borghaei, H., Papadimitrakopoulou, V. A., Patnaik, A., Powell, S. F., Gentzler, R. D., Martins, R. G., Stevenson, J. P., Jalal, S. I., et al. (2016) · The Lancet Oncology
Lung Cancer Treatments and MutationsLung Cancer Diagnosis and Treatment
Cited by 1,404

Go further with a free account

Verify every reference, keep papers in a library, and ask questions across them.

Sign up - it is free